BioPharm America™ 2013
Organization: EBD Group
Venue: The Westin Boston Waterfront
|Event Date/Time: Sep 17, 2013||End Date/Time: Sep 19, 2013|
Beginning its sixth year as an industry event, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.
The backdrop for this intensive business development activity is a three-day conference program that features leading executives from across the life science industry. At BioPharm America held in Boston in September 2012, panel discussions included licensing, investment and business development executives from Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Genentech, Genzyme, Gilead, Ironwood, Janssen Global Services, Merck, Nycomed, Pfizer, and Shire. The event attracted 750+ delegates from 462 companies who participated in 1,840+ scheduled one-to-one meetings.
For information about the BioPharm America 2013 program and registration information, please register your email address for regular updates from EBD Group at firstname.lastname@example.org.